This study investigates inflammatory biomarkers in gingival crevicular fluid (GCF) from smokers and non-smokers with severe periodontitis, before and during non-surgical periodontal therapy (NSPT). During periodontal disease development the periodontal pockets become deeper. In the inflamed periodontal tissue the interstitial fluid is filtered out into the periodontal pocket. The GCF reflects local inflammatory activity and contains cytokines/chemokines that may serve as biomarkers for disease severity and treatment response. Investigators aim at collecting GCF from periodontal pockets from each patients before and during NSPT. Investigators compare non-smokers and smokers. The samples will be analysed for pro-inflammatory mediators and investigators aim at biomarkers that are at a high level in deep inflamed periodontal pockets. Investigators also want to observe if these biomarkers are altered in GCF after periodontal therapy. Finally investigators want to compare non-smokers and smokers with respect to treatment outcome and respons of chemokines/cytokines in GCF.
Age range
16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Biomarker measurement in GCF
Timeframe: Within a period of 5 years